Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening

被引:35
作者
Vrontaki, Eleni [1 ,2 ]
Melagraki, Georgia [1 ]
Mavromoustakos, Thomas [2 ]
Afantitis, Antreas [1 ]
机构
[1] NovaMechanics Ltd, Dept Chemoinformat, Nicosia, Cyprus
[2] Univ Athens, Dept Chem, Organ Chem Lab, GR-10680 Athens, Greece
关键词
3D-QSAR CoMFA; HCV replication inhibitors; molecular docking; PubChem database; virtual screening; HEPATITIS-C VIRUS; DEPENDENT RNA-POLYMERASE; CARBONIC-ANHYDRASE; STRUCTURAL REQUIREMENTS; 3D QSAR; IDENTIFICATION; DERIVATIVES; VALIDATION; DISCOVERY; DESIGN;
D O I
10.3109/14756366.2014.1003925
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A combination of the following computational methods: (i) molecular docking, (ii) 3-D Quantitative Structure Activity Relationship Comparative Molecular Field Analysis (3D-QSAR CoMFA), (iii) similarity search and (iv) virtual screening using PubChem database was applied to identify new anthranilic acid-based inhibitors of hepatitis C virus (HCV) replication. A number of known inhibitors were initially docked into the Thumb Pocket 2 allosteric site of the crystal structure of the enzyme HCV RNA-dependent RNA polymerase (NS5B GT1b). Then, the CoMFA fields were generated through a receptor-based alignment of docking poses to build a validated and stable 3D-QSAR CoMFA model. The proposed model can be first utilized to get insight into the molecular features that promote bioactivity, and then within a virtual screening procedure, it can be used to estimate the activity of novel potential bioactive compounds prior to their synthesis and biological tests.
引用
收藏
页码:38 / 52
页数:15
相关论文
共 80 条
  • [1] Development and evaluation of a QSPR model for the prediction of diamagnetic susceptibility
    Afantitis, Antreas
    Melagraki, Georgia
    Sarimveis, Haralambos
    Koutentis, Panayiotis A.
    Markopoulos, John
    Igglessi-Markopoulou, Olga
    [J]. QSAR & COMBINATORIAL SCIENCE, 2008, 27 (04): : 432 - 436
  • [2] Rational design, efficient syntheses and biological evaluation of N,N′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers
    Agelis, George
    Resvani, Amalia
    Koukoulitsa, Catherine
    Tumova, Tereza
    Slaninova, Jirina
    Kalavrizioti, Dimitra
    Spyridaki, Katerina
    Afantitis, Antreas
    Melagraki, Georgia
    Siafaka, Athanasia
    Gkini, Eleni
    Megariotis, Grigorios
    Grdadolnik, Simona Golic
    Papadopoulos, Manthos G.
    Vlahakos, Demetrios
    Maragoudakis, Michael
    Liapakis, George
    Mavromoustakos, Thomas
    Matsoukas, John
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 62 : 352 - 370
  • [3] [Anonymous], 2007, SYBYL QSAR COMFA MOL, V2007
  • [4] [Anonymous], 2012, SCHROD SUIT 2012 PRO
  • [5] [Anonymous], 2012, MACROMODEL VERS 9 7
  • [6] [Anonymous], 2012, LIGPREP VERS 2 3
  • [7] Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614
  • [8] Boceprevir: A Protease Inhibitor for the Treatment of Hepatitis C
    Chang, Mei H.
    Gordon, Lori A.
    Fung, Horatio B.
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (10) : 2021 - 2038
  • [9] Docking-based CoMFA and CoMSIA analyses of tetrahydro-β-carboline derivatives as type-5 phosphodiesterase inhibitors
    Cichero, Elena
    Bruno, Olga
    Fossa, Paola
    [J]. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (05) : 730 - 743
  • [10] VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD
    CLARK, M
    CRAMER, RD
    VANOPDENBOSCH, N
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) : 982 - 1012